Agenus Newsroom

Agenus Analyst Ratings

BenzingaJun 28 13:31 ET

Buy Rating Affirmed for Agenus Amid Promising Colorectal Cancer Study Results

TipRanksMay 24 14:00 ET

Agenus Analyst Ratings

BenzingaMay 24 07:18 ET

Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), Merus (MRUS) and Iovance Biotherapeutics (IOVA)

TipRanksMay 24 06:25 ET

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Agenus (AGEN)

TipRanksMay 8 08:41 ET

Agenus Analyst Ratings

BenzingaMay 7 14:08 ET

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA), Repligen (RGEN) and Agenus (AGEN)

TipRanksMay 3 07:50 ET

Agenus Shares Target Cut to $5, Analyst Maintains Buy Rating

Investing.com Mar 18 10:26 ET

Agenus Analyst Ratings

BenzingaMar 18 09:24 ET

B. Riley Securities Trims Agenus' Price Target to $5 From $6 After Model Update, Maintains Buy Rating

MT NewswiresMar 18 07:50 ET

Agenus Analyst Ratings

BenzingaMar 14 11:04 ET

Agenus's Promising Botensilimab Leads to Buy Rating From Analyst Mayank Mamtani

TipRanksMar 6 14:35 ET

Analysts Are Bullish on Top Healthcare Stocks: Agenus (AGEN), Zivo Bioscience (ZIVO)

TipRanksJan 25 08:00 ET

Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), Regeneron (REGN) and Warby Parker (WRBY)

TipRanksJan 22 16:00 ET

Positive Outlook for Agenus: Promising Clinical Progress and Effective Financial Management Drive Buy Rating

TipRanksNov 8, 2023 12:45 ET

Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS), Agenus (AGEN) and OrthoPediatrics (KIDS)

TipRanksNov 7, 2023 12:31 ET

B.Riley Financial Sticks to Its Buy Rating for Agenus (AGEN)

TipRanksSep 21, 2023 10:26 ET

Agenus (AGEN) Receives a Buy From Robert W. Baird

TipRanksAug 25, 2023 06:45 ET

B.Riley Financial Sticks to Their Buy Rating for Agenus (AGEN)

TipRanksAug 23, 2023 12:36 ET

Robert W. Baird Keeps Their Buy Rating on Agenus (AGEN)

TipRanksAug 11, 2023 12:16 ET